Update: Prenatal diagnosis for congenital adrenal hyperplasia in 595 pregnancies

Endocrinologist

Volumn 13, Issue 3, 2003, Pages 233-239

  New, Maria I ^a   Carlson, Ann ^a   Obeid, Jihad ^a   Marshall, Ian ^a   Cabrera, Monina S ^a   Goseco, Amanda ^a   Lin Su, Karen ^a   Putnam, Andrea S ^a   Wei, J Qing ^a   Wilson, Robert C ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; STEROID 21 MONOOXYGENASE;

AMNIOCENTESIS; BIRTH WEIGHT; CHORION VILLUS SAMPLING; CONFERENCE PAPER; CONGENITAL ADRENAL HYPERPLASIA; EDEMA; FEMALE; FETUS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEASUREMENT; MOLECULAR GENETICS; NEWBORN; PRADER STAGING; PREGNANCY DIABETES MELLITUS; PRENATAL CARE; PRENATAL DIAGNOSIS; SEX DIFFERENTIATION; SIDE EFFECT; STEROID 21 MONOOXYGENASE DEFICIENCY; STRIA; TREATMENT OUTCOME; VIRILIZATION; WEIGHT GAIN;

EID: 0037929570     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ten.0000081685.21823.46     Document Type: Conference Paper

References (34)

1. New MI: Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). Am J Med 1995;98:2S-8S.
2. White P, Speiser P: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245-91.
3. White PC, New MI, Dupont B: HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci USA 1984;81:7505-9.
4. Meyer-Bahlburg HFL, Gruen R, New MI, et al.: Gender change from female to male in classical CAH. Hormon Behav 1996;30:319-32.
5. New MI, White PC: Genetic disorders of steroid metabolism. In: Thakker RV, ed. Genetic and Molecular Biological Aspects of Endocrine Disease. London: Bailliere Tindall; 1995:525-54.
6. Urban M, Lee P, Migeon C: Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med 1978;299:1392.
7. Clark R, Albertson B, Munabi A, et al.: Steroidogenic enzyme activities, morphology, and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1990;70:1408-13.
8. Srikanth M, West B, Ishitani M, et al.: Benign testicular tumors in children with congenital adrenal hyperplasia. J Pediatr Surg 1992;27:639-41.
9. Premawardhana L, Hughes I, Read G, et al.: Longer-term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol (Oxf) 1997;46:327-32.
10. Pang SY, Wallace MA, Hofman L, et al.: Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 1988;81:866-74.
11. Pang S, Clark A: Newborn screening, prenatal diagnosis, and prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Trends Endocrinol Metab 1990;1:300-7.
12. Pang S, Clark A: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder. Screening 1993;2:105-39.
13. Temeck JW, Pang SY, Nelson C, et al.: Genetic defects of steroidogenesis in premature pubarche. J Clin Endocrinol Metab 1987;64:609-17.
14. Speiser PW, Dupont B, Rubinstein P, et al.: High frequency of non-classical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985;37:650-67.
15. New MI, Wilson RCW: Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci USA 1999;96:12790-7.
16. Higashi Y, Tanae A, Inoue H, et al.: Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products. Proc Natl Acad Sci USA 1988;85:7486-90.
17. Tusie-Luna M, White P: Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci USA 1995;92:10796-800.
18. White PC, New MI, Dupont B: Structure of the human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 1986;83:5111-5.
19. Werkmeister JW, New MI, Dupont B, et al.: Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am J Hum Genet 1986;39:461-9.
20. Higashi Y, Hiromasa T, Tanae A, et al.: Effects of individual mutations in the P-450(C21) pseudogene on the P-450(C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency. J Biochem 1991;109:638-44.
21. Mornet E, Crete P, Kuttenn F, et al.: Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet 1991;48:79-88.
22. Speiser PW, Dupont J, Zhu D, et al.: Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992;90:584-95.
23. Wedell A, Ritzen EM, Haglund SB, et al.: Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations. Proc Natl Acad Sci USA 1992;89:7232-6.
24. Speiser PW, New MI, Tannin GM, et al.: Genotype of Yupik Eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Genetics 1992;88:647-8.
25. Wilson RC, Mercado AB, Cheng KC, et al.: Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995;80:2322-9.
26. Krone N, Braun A, Roscher A, et al.: Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000;85:1059-65.
27. Forest M: Prenatal diagnosis, treatment, and outcome in infants with congenital adrenal hyperplasia. Curr Opin Endocrin Diabet 1998;4:209-17.
28. Carlson AD, Obeid JS, Kanellopoulou N, et al.: Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. In: Labrie F, ed. Xth International Congress on Hormonal Steroids, Quebec. J Steroid Biochem Mol Biol 1999:19-29.
29. Lajic S, Wedell A, Bui T, et al.: Long-term somatic follow-up of prenatally treated children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1998;83:3872-80.
30. Speiser PW, Laforgia N, Kato K, et al.: First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency). J Clin Endocrinol Metab 1990;70:838-48.
31. David M, Forest MG: Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. J Pediatr 1984;105:799-803.
32. Forest MG, Betuel H, David M: Prenatal treatment in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Update 88 of the French multicentric study. Endocr Res 1989;15:277-301.
33. Mercado AB, Wilson RC, Cheng KC, et al.: Extensive personal experience: Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1995;80:2014-20.
34. Wilson RC, Wei JQ, Cheng KC, et al.: Rapid DNA analysis by allele-specific PCR for detection of mutations in the steroid 21-hydroxylase gene. J Clin Endocrinol Metab 1995;80:1635-40.